Professional Documents
Culture Documents
WOS
Scopus
15638
28354
9244
17795
3 IIT Delhi
4 IIT Kharagpur
5 Banaras Hindu University (BHU),
Varanasi
8383
9739
7382
18159
16185
14820
7 IIT Madras
8 IIT Kanpur
9 IIT Bombay
23 Jawaharlal Nehru University
(JNU), New Delhi
7366
7202
7214
2720
13133
13306
11152
4516
2496
3779
42 IIT Guwahati
48 Jamia Millia Islamia, New Delhi
1135
1,639
3104
2055
TT File
DONE
S.No. TT
1
DONE
DONE
DONE
DONE
3
4
5
DONE
DONE
DONE
DONE
6
7
8
9
DONE
10
DONE
Done
11
12
IISC Banglore
Gasifier for Thermal Operation on a KILN
Enhancements to SMODE IFF
Video Compression Using Wavelets
Retargetable Compilers For Motorola DSP Architecture
Spread-001
Spread-002
Spread-003
Robust Speech Recognition Engine
Spread-004
Video Compression
DSP COURSE-SPREAD-006
Course on Data Structures and Algorithms
Course on DSP Applications
Course on Cellular Networks
Radar Video Compression
Feedback Based Strategies for Analysis of Speech Signals
Instruction Enhancement Program on Designing with DSPs
Course on LAX and YACC
Image compression for printing
Spread-012
Speech Information Processing - Development
Technologies
Course on multirate signal processing
of
Algorithms
and
on
Network
Architecture
and
Management
in
Atm
Anti-Diabetic compound
Herbal Soft Drink
Antiulcer Herbal Composition(s)
Wound Healing Herbal Composition(s)
Polymer/Drug synthesis/ Therapeutic Technologies
c Piperidines
IT-BHU
Developed Stack Pollution Controller (1995), unique device to remove SPM and toxic gaseous pollutants from all kinds of indu
Developed Air Pollution Controller for Silver Refineries (1995), Pollutant gas NO2 released from Silver Refineries is recycled &
Developed Pollution Control Technology for Saree Printing Industries (1998), this low cost primary treatment technology is ap
Developed Biological Treatment of Waste Water(1991), This is an economic technology in which aquatic plants are used for re
Developed Treatment Technology for Dairy Waste Water (2003). This low cost technology is developed for tertiary treatment
Developed Air Pollution Control Technology for Brick Industries (2003). This low cost technology is based on wet scrubber me
uents. This low cost technology was highly appreciated by scientists and technologists during Int. Conf. at Vienna and recommended for i
d by a number of Dairies in India.
stacks Brick Industries.
Vienna and recommended for its application for pollution control in tropical countries.
JNU Delhi
Sr. No.
10
11
12
13
JNU Delhi
Brief about Technology
A novel anti-cancer combination therapy
The present invention relates to the identification of new cellular target of micro-RNA- mir-24-2, i.e. BCL-2, an
anti-apoptotic gene, and methods of its use to increase apoptosis (cell death) of cancer cells in presence of 200
400 fold reduced dose of anti-cancer drugs. The approach has the potential to reduce toxicity to non-cancerous
cells considerably and allow improved quality of life during therapeutic intervention. The invention described her
provides a new anti-cancer combination therapy that utilizes over-expression of mir-24-2 to potentiate the
apoptotic pathway by down-regulating the expression of BCL-2, H2AFX, MDM2 and P21 genes. It has been
demonstrated herein that treatment of breast cancer cells, MCF7, with anti-cancer drugs like, Cisplatin along wi
over-expression of micro-RNA, mir-24-2 has additive effect in inducing apoptotic cell death. A patent application
for this IPR protection has been filed in 2011, displayed on Pg No 635 in "Official Journal of The Patent Office;
Issue No 02/2013" (Click Here to Download)
Interested parties who want to bid for the technology may submit their bid in the office of chairperson,
Intellectual Property Management Cell, Room No. 117, Administration Block, Jawaharlal Nehru University, New
Delhi-110067, so as to reach this office on or before 30th November, 2014. For any further clarification and
seeking appointment the interested parties can contact: Prof R N K Bamezai, School of Life Sciences, Jawaharla
Nehru University, New Delhi-110067 by email: bamezai@hotmail.com or phone +91 11 26704518.
In the major cereal grains (wheat, rice, maize etc.), which represent the largest source of food and feed
worldwide, lysine is the most limiting essential amino acid and it is therefore considered as a nutritionally
significant amino acid. Rice is the most important staple food for a large part of world's population, especially in
East and South Asia, the Middle East, Latin America, and the West Indies. Rice grains are deficient in certain
essential amino acids, especially lysine. Lysine plays a major role in calcium absorption; building muscle protein
recovering from surgery or sport injuries; and production of hormones, enzymes and antibodies. It also helps to
prevent herpes and osteoporosis. Lysine deficiency results in appetite loss, poor growth, fatigue, anemia etc. W
need 51 milligrams of lysine, also called L-lysine, for each gram of protein we eat. Therefore, the average woma
should get approximately 2.3 grams of lysine per day, and the average man should get about 2.8 grams. Lysine
promotes proper organ development and muscle growth. It helps in production of carnitine, a nutrient responsib
for converting fatty acids into energy and helping our body to lower the cholesterol. Therefore, efforts are being
made to improve the nutritional quality of rice with high lysine content. In light of these implications, we have
done metabolic engineering in rice to increase its lysine contents. It is also estimated that increasing lysine
content could increase the gross value of rice in world feed market. A patent application for this IPR protection
has been filed.
Interested parties who want to bid for the technology may submit their bid in the office of chairperson
A non-GM based improved rice with higher yields capable of growing under high temperature, mild
drought and poor quality water (salinity)
The present invention provides an improved and novel rice type which is having high yield and is also tolerant to
multiple abiotic stresses (high temperature, drought and salinity or poor quality water). This novel rice type has
the capacity to produce higher grains under control as well as under various abiotic stress conditions. This is a
dwarf rice and hence, easy to handle during farming. This rice plant shows early maturity and short life span th
the wild type (WT, cv IR64). Grain size of this rice with or without husk or after boiling is bigger than the WT.
Grain weight of the developed rice is also higher than that of WT. This rice can be highly suitable for its further
use in industries or in farming. A patent application for this IPR protection has been filed.
Figure: Phenotype of WT and investigated rice plants along with their panicle morphology.
Interested parties who want to bid for the technology may submit their bid in the office of Chairperson
Stable integration of a xenobiotic receptor promoter-reporter DNA construct into human liver cell lin
for evaluating the drugs by high throughput screening
The Pregnane & Xenobiotic Receptor (PXR; NR1I2), a member of the nuclear receptor super-family, is a wellknown xenobiotic sensing receptor. The highly promiscuous nature of PXR allows it to interact with a wide range
of structurally diverse chemicals. Ligand-activated PXR up-regulates the expression of drug-metabolizing enzym
and drug transporters to protect the cell from chemical insults. However, the physiological importance of PXR
extends beyond xenobiotic protection. Most importantly, the regulation of drug-metabolizing enzymes by PXR m
result in clinical drugdrug interactions, in which one drug accelerates the metabolism of a second medication a
may change or cause adverse results. This not only reduces the therapeutic efficacy of many drugs on
combination therapy but may also cause life-threatening situations. Therefore, the complete evaluation and safe
assessment of any drug (clinical or herbal) which is to be administered is indispensable. Although there are
various methods, which are available to assess the pharmacological properties by drug screening, but due to th
high cost, lengthy experimental duration offers only limited use.In this context, a cell based screening approach
for evaluating the therapeutic value and safety assessment of clinical or herbal drugs, xenobiotics and endobioti
are capable of being addressed at two main levels by engaging (i) PXR protein based or (ii) PXR-promoter based
transcription assays:
Cell based screening protocol for 'Level 1' is already available (22, EPO- WO2004016759, USPTO- 20040077080
but cell based screening protocol for 'Level 2' is now possible here. The present claim relates to achievement of
'Level 2' screening for drugs, xenobiotics and endobiotics. This screening is achieved with the use of PXRpromoter-reporter construct that we have developed and stably integrated into a human liver cell line. Additiona
advantages of this stable PXR-promoter-reporter cell line would be in its ability to predict potential drug-drug
interactions, to identify PXR regulatory proteins, and also to evaluate the modulatory effects of an experimental
molecule on PXR promoter activity.
In conclusion, the present invention relates to a stably integrated PXR promoter-reporter construct-cell line
comprising PXR promoter of -1096 to +43 region which is capable of assessing drug's capability to bind and
induce PXR-promoter on its administration, and hence, is capable of indirectly influencing the protein level of th
PXR-promoter on its administration so as to avoid failure of combination therapy. In one embodiment, it relates
a method of preparation of stably integrated PXR promoter-reporter construct-cell line. In another embodiment,
relates to a PXR promoter and to a PXR-promoter-reporter construct.
Interested parties who want to bid for the technology may submit their bid in the office of Chairperso
The present invention provides a hybrid-type histidine kinase gene isolated from indica rice IR64, and being
capable of osmosensing and inducible by multiple stresses, and hence, being capable of improving the multiple
stress tolerance of the crop plants even in subsequent generations so as to make the plants capable of copingwith the more than one environmental abiotic stress conditions, and therefore, increasing the economic value o
the crop plants while maintaining the yield thereof. The present invention also provides a method of isolation of
hybrid-type histidine kinase gene from indica rice IR64, and its functional characteristics and its sequence listing
and cloning, at least, with yeast expression vector and the plant expression vector, and clones produced thereby
and method of improving multiple stress tolerance of crop plant and crop plants having improved multiple stress
tolerance. Patent application (Indian as well as PCT) has been filed.
Interested parties who want to bid for the technology may submit their bid in the office of Chairperso
The present invention relates to a method for enhancing the regeneration frequency of varieties of Brassica sps
wherein the method is characterized by comprising treatment of hypocotyls explants segments of Brassica sps.
with a medium comprising Benzyl Amino Purine and Napthalene Acetic Acid [B1N1 medium], wherein the
treatment results in fast callus initiation, root hairs initiation, appearance of green spots in the callus so formed
and granulation of callus so formed, and appearance of anthocyanin pigmentation in few species of Brassica.
Patent application (Indian as well as PCT) has been filed.
Interested parties who want to bid for the technology may submit their bid in the office of Chairperso
Curcumin, the yellow pigment present in the Indian spice turmeric, has great therapeutic potential. But it has n
yet become possible to use it as a drug due to its poor bioavailability. We have developed the technology to
prepare the nano form of pure curcumin which when administered orally to mice and rats shows about 10 times
increased bioavailability in comparison to normal curcumin and cures Plasmodium yoelii infection in mice. The
nano form of curcumin does not show any toxicity in mice and rats when fed for 21 days at 1gm/Kg body weigh
Feeding 1 gm of curcumin in nano form to healthy human volunteers for 15 days did not show any adverse effe
It retains its bioactivity in the powder form for 1 year when kept at room temperature. Patent application (India
as well as PCT) has been filed to protect our IPR. Interested parties who want to bid for the technology may
submit their bid in the office of Chairperson, Intellectual Property Management Cell, Room no 117, Administratio
Block, JNU, NewDelhi-110067. Tel: 011-26704093, Fax: +91 1126742040 E-mail: ipmcell@mail.jnu.ac.in by 5
pm of 30thJuly, 2010. For any further clarification and seeking appointment the interested parties can
contact: Prof. Santosh K Kar, School of Biotechnology, Jawaharlal Nehru University, New Delhi by
email: santoshkariis@rediffmail.com
The technology for very long life incandescent Bulb and Fluorescent tube
has been developed for normal lighting purposes that can be further modified for several applications. The
invention is of great commercial application and can be exploited very well in next 10-20 years. The Interested
parties are hereby requested to submit a letter of intent to this effect and invited to discuss the invention,
following signing a non-disclosure agreement. The license agreement will include, amongst others, provisions fo
upfront payments, royalty percentages and infringement issues. Intent for the said technology may be submitte
in sealed covers to The Chairperson, Intellectual Property Management cell, Room No.117, Administration Block
Jawaharlal Nehru University, New Delhi-110067, so as to reach this office on or before close of work on Friday,
June 30, 2009. Interested parties may also contact: Prof. Shatendra K Sharma, Director, University Scien
Instrumentation Centre, Jawaharlal Nehru University, New Delhi 110067, India. Tel: (011)-2674260
(0), 9810721748(M) email: sksharma@mail.jnu.ac.in /shatendra@gmail.com
A novelprocess and apparatus for producing metal particles of various sizes(5-20 nm), by electro-exp
The technology has been developed by Prof. Rakesh Bhatnagar of School of Biotechnology (SBT). Interested
parties who want to bid for the said technology may submit their bids by 5.00 p.m. 11th November 2008 in the
office of Chairperson, Intellectual Property Management cell, Room No.117 Administration Block, Jawaharlal
Nehru University, New Delhi-110067.We have developed a DNA vaccine based on a protective antigen of Rabies
virus. Here, the protective antigen was cloned in a DNA vaccine vector, wherein a signal sequence is used to
direct the target antigen to a desired location, so as to generate maximum immune response. This vaccine has
been tested in mice and dog models, wherein it generated high rabies virus neutralizing antibody titers, which
were 64 and 16 times respectively; higher than the minimum adequate titer against rabies as recommended by
WHO. Thus, this DNA vaccine is highly effective in mice and dogs. Further, this vaccine confers 100% protection
on intracerebral rabies virus challenge in mice. Patent regarding this invention has already been filed. (We have
already filed an Indian patent as well as PCT to protect our IPR) Interested parties may also contact: Prof.
Rakesh Bhatnagar F.N.A.Sc.Laboratory of Molecular Biology and Genetic Engineering, School of
Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India.Tel: (011)-26704079,
09891446032Fax: 26742040
The technology has been developed by Prof. Shatendra Sharma of Advanced Instrumentation Facility (AIF).
Interested parties who want to bid for the said technology may submit their bids by 5.00 p.m. 31st December
2008 in the office of Chairperson, Intellectual Property Management cell, Room No.117 Administration Block,
Jawaharlal Nehru University, New Delhi-110067. Interested parties may also contact the inventor: Prof.
Shatendra Sharma Ph.D. F.I.E., F.I.E.T.E., Director, University Science Instrumentation Centre,
Jawaharlal Nehru University, New Delhi 110067, India.Tel: (011)-26742604, 09810721748, Fax:
26742604
An improved Design of Beverage Packing Can
The technology has been developed by Prof. Shatendra Sharma of Advanced Instrumentation Facility (AIF).
Interested parties who want to bid for the said technology may submit their bids by 5.00 p.m. 31st December
2008 in the office of Chairperson, Intellectual Property Management cell, Room No.117 Administration Block,
Jawaharlal Nehru University, New Delhi-110067. Interested parties may also contact the inventor: Prof.
Shatendra Sharma Ph.D. F.I.E., F.I.E.T.E., Director, University Science Instrumentation Centre,
Jawaharlal Nehru University, New Delhi 110067, India.Tel: (011)-26742604, 09810721748, Fax:
26742604
An improved design of Ignition Spark Plug for Internal Combustion Engines
The technology has been developed by Prof. Shatendra Sharma of Advanced Instrumentation Facility (AIF).
Interested parties who want to bid for the said technology may submit their bids by 5.00 p.m. 31st December
2008 in the office of Chairperson, Intellectual Property Management cell, Room No.117 Administration Block,
Jawaharlal Nehru University, New Delhi-110067. Interested parties may also contact the inventor: Prof.
Shatendra Sharma Ph.D. F.I.E., F.I.E.T.E., Director, University Science Instrumentation Centre,
Jawaharlal Nehru University, New Delhi 110067, India.Tel: (011)-26742604, 09810721748, Fax:
26742604
Plant Biotechnology,
Pharmaceutical and Seed
Industries
Plant Biotechnology,
Pharmaceutical and Seed
Industries
Include Pharmaceutical
companies and industries
industries involved in
toxicological evaluation of
xenobiotics (clinical drugs,
herbal drugs pesticides etc) and
endobiotic metabolites.